Verition Fund Management LLC Sangamo Therapeutics, Inc Transaction History

Verition Fund Management LLC

  • $17.4 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$4.27 - $6.39 $53,895 - $80,654
12,622 New
12,622 $62,000
Q4 2019

Feb 14, 2020
SELL
$8.03 - $11.7 $952,141 - $1.39 Million
-118,573 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$9.05 - $12.22 $1.07 Million - $1.45 Million
118,573 New
118,573 $1.07 Million

Others Institutions Holding SGMO

# of Institutions
115
Shares Held
56.4M
Call Options Held
576K
Put Options Held
1.17M
View Full List

About SANGAMO THERAPEUTICS, INC

SGMO Quotes by TradingView
  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $305M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email